miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas

References

• Nagadia R, Pandit P, Coman WB, et al. miRNAs in head and neck cancer revisited. Cell Oncol 2013;36:1-7
   Google Scholar
• Australia CC. Head and neck cancer. 2014. Available from: www.cancer.org.au/about-cancer/types-of-cancer/head-and-neck-cancer.html
   Google Scholar
• Lajer CB, Buchwald CV. The role of human papillomavirus in head and neck cancer. APMIS 2010;118:510-0
   PubMed Web of Science ®Google Scholar
• Michaud DS, Langevin SM, Eliot M, et al. High-risk HPV types and head and neck cancer. Int J Cancer 2014;135(7):1653-61
   PubMed Web of Science ®Google Scholar
• Pfaffe T, Cooper-White J, Beyerlein P, et al. Diagnostic potential of saliva: current state and future applications. Clin Chem 2011;57:675-87
   PubMed Web of Science ®Google Scholar
• Yoshizawa JM, Wong DTW. Salivary microRNAs and oral cancer detection. Methods Mol Biol (Clifton, NJ). 2013;936:313-24
   Google Scholar
• Smith EM, Rubenstein LM, Haugen TH, et al. Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012;2012:571862
   Google Scholar
• Mendelsohn AH, Lai CK, Shintaku IP, et al. Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope 2010;120:1788-94
   PubMed Web of Science ®Google Scholar
• Tran N, Rose BR, O’Brien CJ. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck 2007;29:64-70
   PubMed Web of Science ®Google Scholar
• Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am 2008;22:1125-42, vii
   PubMed Web of Science ®Google Scholar
• Benson E, Li R, Eisele D, Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol 2014;50:565-74
   PubMed Web of Science ®Google Scholar
• Lajer CB, Nauntofte B, Dabelsteen S, et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer 2011;104:830-40
   PubMed Web of Science ®Google Scholar
• Tommasino M, Accardi R, Caldeira S, et al. The role of TP53 in Cervical carcinogenesis. Hum Mut 2003;21:307-12
   Google Scholar
• Robinson M, Sloan P, Shaw R. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol 2010;46:492-6
   Google Scholar
• Xiaohong W, Xing X. Thomas T, et al. microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci USA 2014;111:4262-7
   Google Scholar
• Kessis TD, Slebos RJ, Nelson WG, et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 1993;90:3988-92
   PubMed Web of Science ®Google Scholar
• Robles SJ, Adami GR. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 1998;16:1113-23
   PubMed Web of Science ®Google Scholar
• Shapiro GI, Edwards CD, Ewen ME, Rollins BJ. p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol 1998;18:378-87
   PubMedGoogle Scholar
• zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. In: Compans RW, Cooper MD, Gleba YY, et al. editors. Current topics in microbiology and immunology. Springer; Berlin, Germany: 1977. p. 1-30
   Google Scholar
• Song X, Sturgis EM, Liu J, et al. MicroRNA variants increase the risk of HPV-associated squamous cell carcinoma of the oropharynx in never smokers. PLoS One 2013;8:e56622
   Google Scholar
• Gillison ML, Broutian T, Pickard RKL, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307:693-703
   PubMed Web of Science ®Google Scholar
• Hobbs CGL, Sterne JAC, Bailey M, et al. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006;31:259-9
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol 2005;14:467-75
   PubMed Web of Science ®Google Scholar
• Wald AI, Hoskins EE, Wells SI, et al. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 2011;33:504-12
   PubMedGoogle Scholar
• Heck JE, Eluf-Neto J, Menezes A, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010;39:166-81
   PubMed Web of Science ®Google Scholar
• Avissar M, McClean MD, Kelsey KT, Marsit CJ. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009;30:2059-63
   PubMed Web of Science ®Google Scholar
• Betiol J, Villa L, Sichero L. Impact of HPV infection on the development of head and neck cancer. Braz J Med Biol Res 2013;46:217-26
   Google Scholar
• Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin N Am 2008;22:1125-42
   PubMed Web of Science ®Google Scholar
• De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009;124:1626-36
   PubMed Web of Science ®Google Scholar
• Bui TC, Markham CM, Ross MW, Mullen PD. Examining the association between oral health and oral HPV infection. Cancer Prev Res 2013;6:917-24
   Google Scholar
• Lin K, Roosinovich E, Ma B, et al. Therapeutic HPV DNA vaccines. Immunol Res 2010;47:86-112
   PubMed Web of Science ®Google Scholar
• Szarewski A. Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types. Expert Rev Vaccines 2012;11:645-57
   PubMed Web of Science ®Google Scholar
• Shiiba M, Uzawa K, Tanzawa H. MicroRNAs in head and neck squamous cell carcinoma (HNSCC) and oral squamous cell carcinoma (OSCC). Cancers 2010;2:653-69
   PubMedGoogle Scholar
• Liu X, Chen Z, Yu J, et al. MicroRNA profiling and head and neck cancer. Comp Funct Genomics 2009;2009:11
   Google Scholar
• Cheung O, Sanyal AJ. MicroRNAs. Springer Berlin Heidelberg; Heidelberg, Berlin, Germany: 2010. p. 493-9
   Google Scholar
• Manchester UO. miRBase. 2013. Available from: www.mirbase.org
   Google Scholar
• Liu CJ, Lin SC, Yang CC, et al. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck 2012;34:219-24
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Ferlito M. Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008;105:13421-6
   PubMed Web of Science ®Google Scholar
• Kumar B, Yadav A, Lang J, et al. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS One 2012;7:e37601
   PubMed Web of Science ®Google Scholar
• Harris T, Jimenez L, Kawachi N, et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol 2012;180:917-28
   PubMed Web of Science ®Google Scholar
• Wang X, Wang HK, McCoy JP, et al. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 2009;15:637-47
   PubMed Web of Science ®Google Scholar
• Sun F, Fu H, Liu Q, et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 2008;582:1564-8
   PubMed Web of Science ®Google Scholar
• Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007;104:15472-7
   PubMed Web of Science ®Google Scholar
• Okada N, Keller AC, Wilkinson JE, et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev 2014;28:438-50
   PubMed Web of Science ®Google Scholar
• Mesplède T, Gagnon D, Bergeron-Labrecque F, et al. p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes. J Virol 2012;86:94-107
   Google Scholar
• Todorovic B, Hung K, Massimi P, et al. Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor. J Virol 2012;86:13313-23
   Google Scholar
• Lajer CB, Skotte L, Specht L, et al. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer 2012;106:1526-34
   PubMed Web of Science ®Google Scholar
• Xie X, Piao L, Bullock BN, et al. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma. Oncogene 2014;33:1037-46
   PubMed Web of Science ®Google Scholar
• Suzuki HI, Yamagata K, Sugimoto K, et al. Modulation of microRNA processing by p53. Nature 2009;460:529-33
   PubMed Web of Science ®Google Scholar
• Szafranska-Schwarzbach AE, Adai AT, Lee LS, et al. Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma. Expert Rev Mol Diagn 2011;11:249-57
   PubMed Web of Science ®Google Scholar
• Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009;458:1127-30
   PubMed Web of Science ®Google Scholar
• Gironella M, Seux M, Xie MJ, et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 2007;104:16170-5
   PubMed Web of Science ®Google Scholar
• Cervigne NK, Gilbert R, Gullane P, et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 2009;18:4818-29
   Google Scholar
• Larson RA. Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia. Chemi Biol Interact 2010;184:21-5
   PubMed Web of Science ®Google Scholar
• Uesugi A, Kozaki KI, Tsuruta T, et al. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 2011;71(17):5765-78
   PubMed Web of Science ®Google Scholar
• Wong TS, Gao W, Ho WK, et al. MicroRNA dysregulation in squamous Cell carcinoma of head and neck. In: Li X, editor. Squamous cell carcinoma. InTech; Rijeka, Croatia: 2012. Available from: www.intechopen.com/books/squaomus-cell-carcinoma/microrna-dysregulation-in-squamous-cell-carcinoma-of-head-and-neck
   Google Scholar
• Olson P, Hanahan D, Lu J, et al. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev 2009;23:2152-65
   PubMed Web of Science ®Google Scholar
• Chen LH, Huang PI, Lo WL, et al. MicroRNA as a novel modulator in head and neck squamous carcinoma. J Oncol 2010;2010:135632-15
   Google Scholar
• Tran N, O’Brien CJ, Clark J, Rose B. Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck 2010;32:1099-111
   Google Scholar
• Li Y, Xie X, Wang F, et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 2011;224:484-95
   PubMed Web of Science ®Google Scholar
• Zeng L, Carter AD, Childs SJ. miR-145 Directs Intestinal Maturation in Zebrafish. Proc Natl Acad Sci USA 2009;106:17793-8
   Google Scholar
• Wang G, Mao W, Zheng S, Ye J. Epidermal growth factor receptor-regulated miR-125a-5p – a metastatic inhibitor of lung cancer. FEBS J 2009;276:5571-8
   PubMed Web of Science ®Google Scholar
• Feng R, Zhu Z, Chen X, et al. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010;298:50-63
   PubMed Web of Science ®Google Scholar
• Martinez I, Gardiner AS, Board KF, et al. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008;27:2575-82
   PubMed Web of Science ®Google Scholar